Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Prolactin slows down hair growth in mice.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

The nanohybrid system significantly improved wound healing and showed strong antibacterial activity.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Modified rat stem cells on a special scaffold improved blood vessel formation and wound healing in skin substitutes.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Thyroid hormone affects skin health, with too little causing rough, pale skin and too much leading to smooth, thin skin, and may also impact wound healing and skin conditions.

Lipophilic dyes accumulate more in hair follicles when delivered with surfactant-propylene glycol solutions.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

Finasteride complexes with HPβCD and polymers improve solubility, potentially enhancing hair loss treatment.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

The new drug delivery system releases the drug better in sebum and targets follicles more effectively than the conventional cream.

Hydrogen peroxide and monoethanolamine in hair dye can cause dermatitis and hair loss.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

The conclusion is that measuring how drugs partition into artificial sebum is important for predicting their delivery into hair and sebaceous follicles, and it provides better information than traditional methods.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Finasteride shows promise for female hair loss, but more research needed.

Nanostructured lipid carriers improve minoxidil delivery for hair loss treatment.

Finasteride effectively treats male hair loss, improving growth and density.